皮肤微生物群在玫瑰痤疮发病中的作用及机制研究进展

doi:10.35541/cjd.20200169

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (12): 1122-1125.doi: 10.35541/cjd.20200169

• 综述 • 上一篇

皮肤微生物群在玫瑰痤疮发病中的作用及机制研究进展

李玥玥骆丹

南京医科大学第一附属医院皮肤科 210029

收稿日期:2020-02-25 修回日期:2020-07-25 发布日期:2021-12-01
通讯作者: 骆丹 E-mail:daniluo2005@163.com

Roles and action mechanisms of skin microbiota in the occurrence of rosacea

Li Yueyue, Luo Dan

Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Received:2020-02-25 Revised:2020-07-25 Published:2021-12-01
Contact: Luo Dan E-mail:daniluo2005@163.com

摘要/Abstract

摘要： 【摘要】皮肤微生物群在玫瑰痤疮发病中的作用尚未明确，本文综述了目前报道的与玫瑰痤疮发病可能相关的重要皮肤微生物群，包括蠕形螨、Bacillus oleronius、痤疮丙酸杆菌、Corynebacterium kroppenstedtii等，并进一步探讨其潜在的作用机制。

关键词: 红斑痤疮, 微生物群落, 痤疮丙酸杆菌, 蠕形螨, Bacillus oleronius, Corynebacterium kroppenstedtii

Abstract: 【Abstract】 The role of skin microbiota in the occurrence of rosacea remains unclear. This review summarizes several important skin microorganisms that have been reported to be possibly related to the occurrence of rosacea, including Demodex, Bacillus oleronius, Propionibacterium acnes, Corynebacterium kroppenstedtii, etc., and further elaborates on the potential mechanisms of action.

Key words: Rosacea, Microbial consortia, Propionibacterium acnes, Demodex, Bacillus oleronius, Corynebacterium kroppenstedtii

李玥玥骆丹. 皮肤微生物群在玫瑰痤疮发病中的作用及机制研究进展[J]. 中华皮肤科杂志, 2021,54(12):1122-1125. doi:10.35541/cjd.20200169

Li Yueyue, Luo Dan. Roles and action mechanisms of skin microbiota in the occurrence of rosacea[J]. Chinese Journal of Dermatology, 2021, 54(12): 1122-1125.doi:10.35541/cjd.20200169

参考文献 30

［1］	中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识（2016）［J］. 中华皮肤科杂志, 2017,50（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2017.03.002.
［2］	Chen YE, Fischbach MA, Belkaid Y. Skin microbiota⁃host interactions［J］. Nature, 2018,553（7689）:427⁃436. doi: 10.1038/nature25177.
［3］	闫慧敏, 赵惠娟, 姜薇. 高通量测序分析红斑期酒渣鼻患者与健康人面部皮肤微生物的分布差异［J］. 中国皮肤性病学杂志, 2016,30（10）:991⁃994,997. doi: 10.13735/j.cjdv.1001⁃7089. 201602060.
［4］	Zaidi AK, Spaunhurst K, Sprockett D, et al. Characterization of the facial microbiome in twins discordant for rosacea［J］. Exp Dermatol, 2018,27（3）:295⁃298. doi: 10.1111/exd.13491.
［5］	Rainer BM, Thompson KG, Antonescu C, et al. Characterization and analysis of the skin microbiota in rosacea: a case⁃control study［J］. Am J Clin Dermatol, 2020,21（1）:139⁃147. doi: 10. 1007/s40257⁃019⁃00471⁃5.
［6］	Woo YR, Lee SH, Cho SH, et al. Characterization and analysis of the skin microbiota in rosacea: impact of systemic antibiotics［J］. J Clin Med, 2020,9（1）:185. doi: 10.3390/jcm9010185.
［7］	Chang YS, Huang YC. Role of Demodex mite infestation in rosacea: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2017,77（3）:441⁃447.e6. doi: 10.1016/j.jaad.2017.03. 040.
［8］	Forton F, De Maertelaer V. Rosacea and demodicosis: little⁃known diagnostic signs and symptoms［J］. Acta Derm Venereol, 2019,99（1）:47⁃52. doi: 10.2340/00015555⁃3041.
［9］	Sahni DR, Feldman SR, Taylor SL. Ivermectin 1% （CD5024） for the treatment of rosacea［J］. Expert Opin Pharmacother, 2018,19（5）:511⁃516. doi: 10.1080/14656566.2018.1447562.
［10］	Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes［J］. J Invest Dermatol, 2011,131（3）:688⁃697. doi: 10.1038/jid.2010.351.
［11］	Margalit A, Kowalczyk MJ, Żaba R, et al. The role of altered cutaneous immune responses in the induction and persistence of rosacea［J］. J Dermatol Sci, 2016,82（1）:3⁃8. doi: 10.1016/j.jdermsci.2015.12.006.
［12］	Forton FM. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link［J］. J Eur Acad Dermatol Venereol, 2012,26（1）:19⁃28. doi: 10.1111/j.1468⁃3083. 2011.04310.x.
［13］	Falay Gur T, Erdemir AV, Gurel MS, et al. The investigation of the relationships of demodex density with inflammatory response and oxidative stress in rosacea［J］. Arch Dermatol Res, 2018,310（9）:759⁃767. doi: 10.1007/s00403⁃018⁃1857⁃1.
［14］	Altunisik N, Turkmen D, Sener S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation［J］. J Cosmet Dermatol, 2020,19（8）:2105⁃2108. doi: 10.1111/jocd.13254.
［15］	Lacey N, Russell⁃Hallinan A, Zouboulis CC, et al. Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea［J］. Br J Dermatol, 2018,179（2）:420⁃430. doi: 10.1111/bjd.16540.
［16］	Li T, Zeng Q, Chen X, et al. The therapeutic effect of artesunate on rosacea through the inhibition of the JAK/STAT signaling pathway［J］. Mol Med Rep, 2018,17（6）:8385⁃8390. doi: 10. 3892/mmr.2018.8887.
［17］	Gazi U, Gureser AS, Oztekin A, et al. Skin⁃homing T⁃cell responses associated with Demodex infestation and rosacea［J］. Parasite Immunol, 2019,41（8）:e12658. doi: 10.1111/pim.12658.
［18］	Forton F, De Maertelaer V. Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case⁃control study［J］. Br J Dermatol, 2019,181（4）:818⁃825. doi: 10. 1111/bjd.17817.
［19］	Forton F, De Maertelaer V. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms［J］. J Eur Acad Dermatol Venereol, 2020,34（2）:365⁃369. doi: 10.1111/jdv.15938.
［20］	McMahon FW, Gallagher C, O′Reilly N, et al. Exposure of a corneal epithelial cell line （hTCEpi） to Demodex⁃associated Bacillus proteins results in an inflammatory response［J］. Invest Ophthalmol Vis Sci, 2014,55（10）:7019⁃7028. doi: 10.1167/iovs. 14⁃15018.
［21］	Maher A, Staunton K, Kavanagh K. Analysis of the effect of temperature on protein abundance in Demodex⁃associated Bacillus oleronius［J］. Pathog Dis, 2018,76（4）. doi: 10.1093/femspd/fty032.
［22］	O′Reilly N, Bergin D, Reeves EP, et al. Demodex⁃associated bacterial proteins induce neutrophil activation［J］. Br J Dermatol, 2012,166（4）:753⁃760. doi: 10.1111/j.1365⁃2133.2011.10746.x.
［23］	McMahon F, Banville N, Bergin DA, et al. Activation of neutrophils via IP3 pathway following exposure to Demodex⁃associated bacterial proteins［J］. Inflammation, 2016,39（1）:425⁃433. doi: 10.1007/s10753⁃015⁃0264⁃4.
［24］	Jahns AC, Lundskog B, Dahlberg I, et al. No link between rosacea and Propionibacterium acnes［J］. APMIS, 2012,120（11）:922⁃925. doi: 10.1111/j.1600⁃0463.2012.02920.x.
［25］	Thompson KG, Rainer BM, Antonescu C, et al. Comparison of the skin microbiota in acne and rosacea［J/OL］. Exp Dermatol, 2020. ［2020⁃04⁃11］. doi: 10.1111/exd.14098. ［published online ahead of print Apr 11,2020］.
［26］	Tauch A, Fernández⁃Natal I, Soriano F. A microbiological and clinical review on Corynebacterium kroppenstedtii［J］. Int J Infect Dis, 2016,48:33⁃39. doi: 10.1016/j.ijid.2016.04.023.
［27］	Clanner⁃Engelshofen BM, French LE, Reinholz M. Corynebacterium kroppenstedtii subsp. demodicis is the endobacterium of Demodex folliculorum［J］. J Eur Acad Dermatol Venereol, 2020,34（5）:1043⁃1049. doi: 10.1111/jdv. 16069.
［28］	Sobolewska B, Doycheva D, Deuter CM, et al. Efficacy of topical ivermectin for the treatment of cutaneous and ocular rosacea［J/OL］. Ocul Immunol Inflamm, 2020. ［2020⁃04⁃07］. doi: 10.1080/09273948.2020.1727531. ［published online ahead of print Apr 7,2020］.
［29］	Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase Ⅲ clinical trials evaluating anti⁃inflammatory dose doxycycline （40⁃mg doxycycline, USP capsules） administered once daily for treatment of rosacea［J］. J Am Acad Dermatol, 2007,56（5）:791⁃802. doi: 10.1016/j.jaad.2006.11.021.
［30］	Gold LS, Del Rosso JQ, Kircik L, et al. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials［J］. J Am Acad Dermatol, 2020,82（5）:1166⁃1173. doi: 10.1016/j.jaad.2020.01.043.

[1]	刘宇甄曾荣郑娜娜段志敏徐浩翔吴秋菊林彤李岷. 氨基酮戊酸孵育不同时间对光动力疗法抑制痤疮丙酸杆菌生物膜效应的影响[J]. 中华皮肤科杂志, 2022, 55(3): 208-212.
[2]	李海洋林尽染刘庆梅倪春雅吴文育. 微生物群与头皮毛发疾病相关性研究进展[J]. 中华皮肤科杂志, 2022, 0(1): 20201196-e20201196.
[3]	王小燕, 张嘉文, 刘韵祎, 刘乙萱, 姜沛彧, 李敏, 陶梦, 许阳. 玫瑰痤疮的皮肤影像学和无创检测技术相关进展[J]. 中华皮肤科杂志, 2022, 0(1): 20200939-e20200939.
[4]	中华医学会皮肤性病学分会玫瑰痤疮研究中心中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）[J]. 中华皮肤科杂志, 2021, 54(4): 279-288.
[5]	李健宋志强. 玫瑰痤疮面部潮红与红斑新认识[J]. 中华皮肤科杂志, 2021, 54(4): 360-363.
[6]	邓青刘芳芬施为谢红付李吉黄莹雪. 长沙地区玫瑰痤疮患者的支付意愿调查及影响因素分析[J]. 中华皮肤科杂志, 2021, 54(4): 352-355.
[7]	张二佳林彤. 两种强脉冲光治疗玫瑰痤疮的疗效观察[J]. 中华皮肤科杂志, 2021, 54(3): 207-211.
[8]	闫慧敏杜笑孟令贺翁立硕曾三武. 基于16S rRNA基因测序的慢性自发性荨麻疹患者肠道菌群差异研究[J]. 中华皮肤科杂志, 2021, 54(12): 1071-1076.
[9]	宋晓婷, 刘擘, 陈玉迪, 赵作涛. 玫瑰痤疮的病理生理发病机制研究进展[J]. 中华皮肤科杂志, 2021, 0(1): 20200178-e20200178.
[10]	刘乙萱, 姜沛彧, 刘韵祎, 张嘉文, 陶梦, 李敏, 许阳. 玫瑰痤疮神经源性炎症及肉毒毒素治疗相关机制的研究进展[J]. 中华皮肤科杂志, 2021, 0(1): 20200266-e20200266.
[11]	张红燕, 李丽, 王明霞, 董银卯, 孟宏, 易帆. 益生菌在痤疮治疗中的应用进展[J]. 中华皮肤科杂志, 2021, 0(1): 20200657-e20200657.
[12]	李容, 张家安, 陈崑. 玫瑰痤疮光电疗法研究进展[J]. 中华皮肤科杂志, 2021, 0(1): 20201002-e20201002.
[13]	陶梦, 李敏, 刘乙萱, 刘韵祎, 姜沛彧, 张嘉文, 南宇晴, 许阳. 玫瑰痤疮与精神神经性疾病相关性研究进展[J]. 中华皮肤科杂志, 2021, 0(1): 20201083-e20201083.
[14]	王亚玲, 谢红付, 李吉, 汪犇. JAK-STAT信号通路与玫瑰痤疮[J]. 中华皮肤科杂志, 2021, 0(1): 20200592-e20200592.
[15]	周园, 姚煦. 微生物群体感应系统在皮肤炎症发展中的作用机制[J]. 中华皮肤科杂志, 2021, 0(1): 20200902-e20200902.

皮肤微生物群在玫瑰痤疮发病中的作用及机制研究进展

Roles and action mechanisms of skin microbiota in the occurrence of rosacea

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

Metrics

本文评价

推荐阅读 10